Clinical Trial Update: Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML [Phase 3]

View source ↗

Summary

Phase III randomized trial investigating decitabine with or without hydroxyurea versus hydroxyurea alone in advanced proliferative CMML/MDS-related condition ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: MDS | Phase 3 | Status: COMPLETED